207_Combined course Presentations

Guidance for industry Clinical trials Endpoints for the approval of cancer drugs FDA, May 2007 “Overall survival is considered the most reliable cancer endpoint, and when studies can be conducted to adequately assess survival, it is usually the preferred endpoint.”